KRRO
Korro Bio, Inc.- Healthcare
- Biotechnology
- $138M market cap
Forecast run · Sep 14, 2026Upside rank 303 of 3,136
Model Signal
ForecastQ Daily Probabilities
61.9%
57.4%
54.4%
Analyst Consensus
Recommendation2.17/5 Buy
Last price$13.81
Price target$15.00
Implied move+8.6%
Analysts12
ForecastQ Portfolios
KRRO is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.